As of December 31, 2024, the Company was authorized to issue 500.0 million shares of common stock, par value $0.001 per share. As of December 31, 2023, the Company was authorized to issue 260.6 million shares of common stock, par value $0.001 per share.

In June 2023, the Company amended and restated its certificate of incorporation to, among other things, increase the authorized number of shares of common stock of the Company to 260.6 million shares.

In October 2024, the Company amended and restated its certificate of incorporation, which was filed immediately prior to the closing of its IPO and among other things, increased the number of shares of common stock authorized for issuance to 500.0 million shares of common stock.

In October 2024, the Company completed its IPO of its common stock. In connection with the Company's IPO, the Company issued and sold 18.4 million shares of its common stock, which included an additional 2.4 million shares of common stock that were issued to the underwriters pursuant to the full exercise of their option to purchase additional shares of common stock, at the public offering price of $18.00 per share. As a result, the Company received $302.8 million in net proceeds, after deducting underwriting discounts and commissions and other offering costs payable by the Company of $28.4 million.

The holders of common stock are entitled to dividends when and if declared by the board of directors, subject to the preferences applicable to outstanding shares of the Preferred Stock. The board of directors has not declared any dividends and the Company has not paid any dividends. The holders of common stock are entitled to one vote per share on all matters to be voted upon by the stockholders.

The Company reserved the following shares of common stock, on an as-converted basis, for future issuance:


	As of December 31,
	2024		2023
Series A Convertible Preferred Stock		—		8,710,490
Series B Convertible Preferred Stock		—		14,129,284
Options issued and outstanding		2,938,982		1,123,296
Shares reserved for future grants under 2021 Plan		—		1,634,488
Shares reserved for future grants under 2024 Plan		3,743,915		—
Shares reserved for 2024 ESPP		369,402		—
		7,052,299		25,597,558